Driven by Our Promise
It began with a promise. More than 100 years ago, CSL was formed to save lives using the latest technologies. In the century since, CSL Behring has grown into a global biotechnology leader, driven by that same promise to save and improve lives. We offer the broadest range of quality plasma-derived and recombinant therapies in our industry. Our ability to innovate and deliver life-saving medicines for patients with unmet medical needs around the world has earned us a reputation for always putting patients first. We are CSL Behring and we are driven by our promise.
CSL Behring AG in Bern
Our company specializes in the manufacture of biotherapeutic products. She has over a century of experience in treating different diseases around the world. We are committed to patients suffering from blood clotting disorders, immunological diseases, enzymatic deficits and other rare diseases.
In addition, we produce biotherapeutic drugs to stop bleeding in emergencies or planned surgeries.
CSL Behring in Lengnau
Thermo Fisher Scientific Inc., the world leader in serving science, and global biotechnology company, CSL Limited have entered into a strategic partnership to help meet the growing demand for biologic therapies while also accelerating CSL’s broader manufacturing objectives.
Focus on Rare & Serious Diseases
We are a biotechnology company, involved for more than a century with research and development related to severe and rare diseases, giving our support to patients with severe diseases.Learn More
CSL’s strong commitment to living our Values has guided us for many decades. Our Values have been fundamental to our success -- helping us to save lives, protect the health of people, and earn our reputation as a trusted and reliable global leader. They’re at the core of how our employees interact with each other, make decisions and solve problems. They are:
We deliver on our promise to patients.
We turn innovative thinking into solutions.
We walk the talk.
We are stronger together.
We take pride in our results.